journal article Open Access Nov 11, 2011

Water Soluble Polymers for Pharmaceutical Applications

Polymers Vol. 3 No. 4 pp. 1972-2009 · MDPI AG
View at Publisher Save 10.3390/polym3041972
Abstract
Advances in polymer science have led to the development of novel drug delivery systems. Some polymers are obtained from natural resources and then chemically modified for various applications, while others are chemically synthesized and used. A large number of natural and synthetic polymers are available. In the present paper, only water soluble polymers are described. They have been explained in two categories (1) synthetic and (2) natural. Drug polymer conjugates, block copolymers, hydrogels and other water soluble drug polymer complexes have also been explained. The general properties and applications of different water soluble polymers in the formulation of different dosage forms, novel delivery systems and biomedical applications will be discussed.
Topics

No keywords indexed for this article. Browse by subject →

References
235
[1]
Will, R., Loechner, U., and Yokose, K. Synthetic Water Soluble Polymers. Available online: http://www.sriconsulting.com/CEH/Public/Reports/582.0000/ (accessed on 28 June 2011).
[2]
Veronese "PEGylation, Successful Approach to Drug Delivery" Drug Discovery Today (2005) 10.1016/s1359-6446(05)03575-0
[3]
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives

Katrin Knop, Richard Hoogenboom, Dagmar Fischer et al.

Angewandte Chemie International Edition 2010 10.1002/anie.200902672
[4]
Leroux "In Situ-Forming Hydrogels—Review of Temperature-Sensitive Systems" Eur. J. Pharm. Biopharm. (2004) 10.1016/j.ejpb.2004.03.019
[5]
Martens "Synthesis and Characterization of Degradable Hydrogels Formed from Acrylate Modified Poly(vinyl alcohol) Macromers" Polymer (2002) 10.1016/s0032-3861(02)00561-x
[6]
Bhadra "Pegnology: A Review of PEG-ylated Systems" Pharmazie (2002)
[7]
Monfardini "Stabilization of Substances in Circulation" Bioconjugate Chem. (1998) 10.1021/bc970184f
[8]
Polymer–drug conjugation, recent achievements and general strategies

G. Pasut, F.M. Veronese

Progress in Polymer Science 2007 10.1016/j.progpolymsci.2007.05.008
[9]
Allen "Drug Delivery Systems: Entering the Mainstream" Science (2004) 10.1126/science.1095833
[10]
Duncan "Polymer-Drug Conjugates: Towards a Novel Approach for the Treatment of Endocrine-Related Cancer" Endocr. Relat. Cancer (2005) 10.1677/erc.1.01045
[11]
Savient Pharmaceuticals, Inc. Product Pipeline—Overview. Available online: http://savientpharma.com/pipeline/ (accessed on 13 August 2011).
[12]
Pasut "PEG Conjugates in Clinical Development or Use as Anticancer Agents: An Overview" Adv. Drug Deliv. Rev. (2009) 10.1016/j.addr.2009.02.010
[13]
Burnham "Polymers for Delivering Peptides and Proteins" Am. J. Hosp. Pharm. (1994)
[14]
Eldon, M.A., Staschen, C.M., Viegas, T., and Bentley, M. (2007, January 22–26). NKTR-102, a Novel PEGylated Irinotecan Conjugate, Results in Sustained Tumor Growth Inhibition in Mouse Models of Human Colorectal and Lung Tumors that is Associated with Increased and Sustained Tumor SN38 Exposure. San Francisco, CA, USA. poster C157.
[15]
Von Hoff, D.D., Jameson, G.S., Borad, M.J., Rosen, L.S., Utz, J., Basche, M., Alemany, C., Dhar, S., Acosta, L., and Barker, T. (2008, January 21–24). First Phase I Trial of NKTR-102 (PEG-Irinotecan) Reveals Early Evidence of Broad Anti-Tumour Activity in Three Different Schedules. Geneva, Switzerland. poster#595. 10.1016/s1359-6349(08)72529-1
[16]
NKTR-105. Available online: http://www.nektar.com/product_pipeline/oncology_nktr-105.html (accessed on 12 August 2011).
[17]
Zhao "20-Oacylcamptothecin Derivatives: Evidence for Lactone Stabilization" J. Org. Chem. (2000) 10.1021/jo000221n
[18]
Scott "A Phase II Study of Pegylatedcamptothecin (Pegamotecan) in the Treatment of Locally Advanced and Metastatic Gastric and Gastro-Oesophageal Junction Adenocarcinoma" Cancer Chemother. Pharmacol. (2009) 10.1007/s00280-008-0746-2
[19]
Sapra "Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camptothecin-11-Refractory Model" Clin. Cancer Res. (2008) 10.1158/1078-0432.ccr-07-4456
[20]
Jeong "Thermoreversible Gelation of PEG-PLGA-PEG Triblock Copolymer Aqueous Solutions" Macromolecules (1999) 10.1021/ma9908999
[21]
Chowhan "Role of Binders in Moisture-Induced Hardness Increase in Compressed Tablets and Its Effect on in vitro Disintegration and Dissolution" J. Pharm. Sci. (1980) 10.1002/jps.2600690102
[22]
Chowhan "Punch Geometry and Formulation Considerations in Reducing Tablet Friability and Their Effect on in vitro Dissolution" J. Pharm. Sci. (1992) 10.1002/jps.2600810320
[23]
Jun "Preparation and Evaluation of Acetaminophen Tablets" Kor. Pharm. Sci. (1989)
[24]
Sinchalpanid "Comparative Evaluation of Hydroxypropyl Cellulose and Povidone in Paracetamol Tablet Formulations" Mahidol J. Pharm. Sci. (1993)
[25]
Stone, I.M. (1963). (U.S. Patent 3,089,818), Water Dispersible Antibiotics.
[26]
Forster "Characterization of Glass Solutions of Poorly Water-Soluble Drugs Produced by Melt Extrusion with Hydrophilic Amorphous Polymers" J. Pharm. Pharmacol. (2001) 10.1211/0022357011775532
[27]
Jijun "Nimodipine (NM) Tablets with High Dissolution Containing NM Solid Dispersions Prepared by Hot-Melt Extrusion" Drug Dev. Ind. Pharm. (2011) 10.3109/03639045.2010.550301
[28]
He "In vitro and in vivo Evaluation of Fenofibrate Solid Dispersion Prepared by Hot-Melt Extrusion" Drug Dev. Ind. Pharm. (2010) 10.3109/03639040903449720
[29]
Chokshi "Characterization of Physico-Mechanical Properties of Indomethacin and Polymers to Assess Their Suitability for Hot-Melt Extrusion Process as a Means to Manufacture Solid Dispersion/Solution" J. Pharm. Sci. (2005) 10.1002/jps.20385
[30]
Jachowicz "Dissolution Rates of Partially Water Soluble Drugs from Solid Dispersion Systems. II. Phenytoin" Int. J. Pharm. (1987) 10.1016/0378-5173(87)90068-8
[31]
White, R.K. (1994). Pharmaceutical Compositions Containing Polyvinylpyrrolidone and a Tri-Ester and a Process of Manufacture Thereof. Internat. (Patent WO/1994/025008).
[32]
Bühler, V. (2005). Polyvinylpyrrolidone Excipients for Pharmaceuticals: Povidone, Crospovidone and Povidone, Springer. [1st ed.].
[33]
Tubbs "Sequence Distribution of Partially Hydrolyzed Poly(vinyl acetate)" J. Polym. Sci. (1966) 10.1002/pol.1966.150040316
[34]
Tacx "Dissolution Behavior and Solution Properties of Polyvinylalcohol as Determined by Viscometry and Light Scattering in DMSO, Ethylene Glycol and Water" Polymer (2000) 10.1016/s0032-3861(99)00220-7
[35]
Hassan "Structure and Applications of Poly(vinyl alcohol) Hydrogels Produced by Conventional Crosslinking or by Freezing/Thawing Methods" Adv. Polym. Sci. (2000) 10.1007/3-540-46414-x_2
[36]
Reneker "Bending Instability of Electrically Charged Liquid Jets of Polymer Solutions in Electrospinning" J. Appl. Phys. (2000) 10.1063/1.373532
[37]
Krishna "Polyvinyl Alcohol as an Ophthalmic Vehicle. Effect on Regeneration of Corneal Epithelium" Am. J. Opthalmol. (1964) 10.1016/0002-9394(64)92038-0
[38]
Paton "Ocular Evaluation of Polyvinyl Alcohol Vehicle in Rabbits" J. Pharm. Sci. (1975) 10.1002/jps.2600640811
[39]
Wan "Drug Release from Heat Treated Polyvinyl Alcohol Films" Drug Dev. Ind. Pharm. (1992) 10.3109/03639049209046338
[40]
Saunders, G., and MacCreath, B. (2010). Biodegradable Polymers Analysis of Biodegradable Polymers by GPC-SEC. Application Compendium, Agilent Technologies Inc.
[41]
Bromberg "Polyether-Modified Poly(acrylic acid): Synthesis and Applications" Ind. Eng. Chem. Res. (1998) 10.1021/ie980358s
[42]
Craig "An Investigation into the Structure and Properties of Carbopol® 934 Gels Using Dielectric Spectroscopy and Oscillatory Rheometry" J. Control. Release (1994) 10.1016/0168-3659(94)90027-2
[43]
Ayers "Polyacrylic Acid Mediated Ocular Delivery of Ribozymes" J. Control. Release (1996) 10.1016/0168-3659(95)00117-4
[44]
Dubin, P., Bock, J., Davis, R., Schulz, D.N., and Thies, C. (1994). Macromolecular Complexes in Chemistry and Biology, Springer-Verlag. 10.1007/978-3-642-78469-9
[45]
Shalaby, S.W., McCormick, C.L., and Butler, G.B. (1991). Water Soluble Polymers, American Chemical Society. 10.1021/bk-1991-0467
[46]
(2010). Polymers for Pharmaceutical Applications, Lubrizol Pharmaceutical Bulletin 1; Lubrizol.
[47]
Weintraub "Acrylamide Gel as a Supporting Medium for Zone Electrophoresis" Science (1959) 10.1126/science.130.3377.711.a
[48]
Raymond "Protein Purification by Elution Convection Electrophoresis" Science (1964) 10.1126/science.146.3642.406
[49]
Chrambach "Polyacrylamide Gel Electrophoresis" Science (1971) 10.1126/science.172.3982.440
[50]
Davis "Control of Diabetes with Polyacrylamide Implants Containing Insulin" Experientia (1972) 10.1007/bf01928732

Showing 50 of 235 references

Cited By
502
PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters

Karol Yesenia Hernández-Giottonini, Rosalva Josefina Rodríguez-Córdova · 2020

RSC Advances
Journal of Environmental Chemical E...
Metrics
502
Citations
235
References
Details
Published
Nov 11, 2011
Vol/Issue
3(4)
Pages
1972-2009
License
View
Cite This Article
Veeran Gowda Kadajji, Guru V. Betageri (2011). Water Soluble Polymers for Pharmaceutical Applications. Polymers, 3(4), 1972-2009. https://doi.org/10.3390/polym3041972
Related

You May Also Like

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier

Hirenkumar K. Makadia, Steven J. Siegel · 2011

3,980 citations

Chitosan: An Overview of Its Properties and Applications

Inmaculada Aranaz, Andrés R. Alcántara · 2021

1,433 citations

Thermoresponsive Polymers for Biomedical Applications

Mark A. Ward, Theoni K. Georgiou · 2011

1,048 citations